Inogen Share Price (NASDAQ: INGN)

$7.99

▲

0.03

(0.38%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Inogen Stock chart to analyse performance

Inogen stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.86
Today's High:$7.99
$7.99
1.63%
Downside
Day's Volatility :1.63%
Upside
0.0%
52 Weeks Low:$5.70
52 Weeks High:$12.95
$7.99
28.66%
Downside
52 Weeks Volatility :55.97%
Upside
38.28%

Inogen Stock Returns

Period	Inogen Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	25.47%	3.6%	0.0%
6 Months	-1.85%	-7.7%	0.0%
1 Year	-31.68%	-12.6%	0.0%
3 Years	-72.27%	9.5%	-4.7%

Inogen Inc Key Stats

Check Inogen key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.96
Open	$7.97
Today's High	$7.99
Today's Low	$7.86
Market Capitalization	$215.2M
Today's Volume	$167.4K
52 Week High	$12.9459
52 Week Low	$5.7
Revenue TTM	$343.5M
EBITDA	$-10.2M
Earnings Per Share (EPS)	$-1.06
Profit Margin	-7.58%
Quarterly Earnings Growth YOY	0.87%
Return On Equity TTM	-13.46%

Stock Returns calculator for Inogen Stock including INR - Dollar returns

The Inogen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inogen investment value today

Current value as on today

₹73,692

Returns

₹26,308

(-26.31%)

Returns from Inogen Stock

₹31,592 (-31.59%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inogen Stock

100%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inogen Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inogen Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
6.57%
Vanguard Group Inc
6.12%
Kent Lake PR LLC
3.92%
Acadian Asset Management LLC
3.80%
Camber Capital Management LLC
3.61%
Ameriprise Financial Inc
3.23%

Analyst Recommendation on Inogen Stock

Rating

Trend

Sell

11%Buy

44%Hold

44%Sell

Based on 9 Wall street analysts offering stock ratings for Inogen(by analysts ranked 0 to 5 stars)

Inogen Share Price Target

What analysts predicted

Upside of 37.67%

Target:

$11.00

Current:

$7.99

Inogen share price target is $11.00, a slight Upside of 37.67% compared to current price of $7.99 as per analysts' prediction.

Inogen Stock Insights

Price Movement
In the last 1 month, INGN stock has moved up by 21.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 80.08M → 92.27M (in $), with an average increase of 6.8% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -9.75M → -4.15M (in $), with an average increase of 53.4% per quarter
INGN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 64.0%
INGN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 236.3%
Price to Sales
ForINGN every $1 of sales, investors are willing to pay $0.6, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Inogen Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$361.9M	↑ 1.07%
Net Income	$21.0M	↓ 59.59%
Net Profit Margin	5.79%	↓ 8.69%

	FY20	Y/Y Change
Revenue	$308.5M	↓ 14.77%
Net Income	$-5.8M	↓ 127.82%
Net Profit Margin	-1.89%	↓ 7.68%

	FY21	Y/Y Change
Revenue	$358.0M	↑ 16.05%
Net Income	$-6.3M	↑ 8.65%
Net Profit Margin	-1.77%	↑ 0.12%

	FY22	Y/Y Change
Revenue	$377.2M	↑ 5.37%
Net Income	$-83.8M	↑ 1222.79%
Net Profit Margin	-22.21%	↓ 20.44%

	FY23	Y/Y Change
Revenue	$315.7M	↓ 16.32%
Net Income	$-102.4M	↑ 22.3%
Net Profit Margin	-32.46%	↓ 10.25%

	FY24	Y/Y Change
Revenue	$335.7M	↑ 6.35%
Net Income	$-35.9M	↓ 64.97%
Net Profit Margin	-10.69%	↑ 21.77%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$78.0M	↑ 2.81%
Net Income	$-14.6M	↓ 45.1%
Net Profit Margin	-18.68%	↑ 16.31%

	Q2 FY24	Q/Q Change
Revenue	$88.8M	↑ 13.76%
Net Income	$-5.6M	↓ 61.65%
Net Profit Margin	-6.3%	↑ 12.38%

	Q3 FY24	Q/Q Change
Revenue	$88.8M	↑ 0.08%
Net Income	$-6.0M	↑ 6.67%
Net Profit Margin	-6.71%	↓ 0.41%

	Q4 FY24	Q/Q Change
Revenue	$80.1M	↓ 9.85%
Net Income	$-9.8M	↑ 63.63%
Net Profit Margin	-12.18%	↓ 5.47%

	Q1 FY25	Q/Q Change
Revenue	$82.3M	↑ 2.75%
Net Income	$-6.2M	↓ 36.72%
Net Profit Margin	-7.5%	↑ 4.68%

	Q2 FY25	Q/Q Change
Revenue	$92.3M	↑ 12.15%
Net Income	$-4.2M	↓ 32.75%
Net Profit Margin	-4.5%	↑ 3.0%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$171.9M	↓ 3.76%

	FY20	Y/Y Change
Profit	$138.2M	↓ 19.6%

	FY21	Y/Y Change
Profit	$176.5M	↑ 27.72%

	FY22	Y/Y Change
Profit	$153.5M	↓ 13.0%

	FY23	Y/Y Change
Profit	$126.7M	↓ 17.48%

	FY24	Y/Y Change
Profit	$154.7M	↑ 22.13%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$33.4M	↑ 18.75%

	Q2 FY24	Q/Q Change
Profit	$47.2M	↑ 41.0%

	Q3 FY24	Q/Q Change
Profit	$41.3M	↓ 12.31%

	Q4 FY24	Q/Q Change
Profit	$36.3M	↓ 12.23%

	Q1 FY25	Q/Q Change
Profit	$36.4M	↑ 0.23%

	Q2 FY25	Q/Q Change
Profit	$35.7M	↓ 1.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$40.6M	↓ 32.32%
Investing Cash Flow	$-44.1M	↑ 76.48%
Financing Cash Flow	$4.9M	↓ 73.06%

	FY20	Y/Y Change
Operating Cash Flow	$37.0M	↓ 8.82%
Investing Cash Flow	$-25.6M	↓ 41.8%
Financing Cash Flow	$2.1M	↓ 58.08%

	FY21	Y/Y Change
Operating Cash Flow	$23.6M	↓ 36.15%
Investing Cash Flow	$-14.6M	↓ 42.88%
Financing Cash Flow	$15.0M	↑ 626.04%

	FY22	Y/Y Change
Operating Cash Flow	$-37.5M	↓ 258.81%
Investing Cash Flow	$-10.9M	↓ 25.73%
Financing Cash Flow	$380.0K	↓ 97.47%

	FY23	Y/Y Change
Operating Cash Flow	$-3.2M	↓ 91.38%
Investing Cash Flow	$-59.3M	↑ 445.32%
Financing Cash Flow	$960.0K	↑ 152.63%

	FY24	Y/Y Change
Operating Cash Flow	$5.9M	↓ 282.87%
Investing Cash Flow	$-14.0M	↓ 76.44%
Financing Cash Flow	$265.0K	↓ 72.4%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-4.7M	↑ 50.86%
Investing Cash Flow	$-13.4M	↓ 425.68%
Financing Cash Flow	$285.0K	↓ 2135.71%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$6.7M	↓ 240.85%
Investing Cash Flow	$-12.4M	↓ 7.94%
Financing Cash Flow	$-201.0K	↓ 170.53%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$7.0M	↑ 4.53%
Investing Cash Flow	$305.0K	↓ 102.46%
Financing Cash Flow	$441.0K	↓ 319.4%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.0M	↓ 143.16%
Investing Cash Flow	$11.5M	↑ 3683.61%
Financing Cash Flow	$-260.0K	↓ 158.96%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-16.8M	↑ 456.33%
Investing Cash Flow	$-2.0M	↓ 117.66%
Financing Cash Flow	$24.0M	↓ 9311.92%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$4.4M	↓ 125.91%
Investing Cash Flow	$-22.6M	↑ 1007.61%
Financing Cash Flow	$0.0	↓ 100.0%

Inogen Technicals Summary

Sell

Neutral

Buy

Inogen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Inogen Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inogen Inc	26.47%	-1.85%	-31.68%	-72.27%	-72.43%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inogen Inc	NA	NA	3.48	-0.46	-0.13	-0.06	NA	7.38
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inogen Inc	Sell	$215.2M	-72.43%	NA	-7.58%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Inogen Inc

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Organization	Inogen
Employees	766
CEO	Mr. Kevin R. M. Smith
Industry	Health Technology

Key Management of Inogen Inc

Name	Title
Mr. Kevin R. M. Smith	President, CEO & Director
Mr. Michael J. Bourque CPA	Executive VP, CFO & Corporate Treasurer
Mr. Kevin P. Smith	General Counsel, Secretary & Executive VP of Business Development
Mr. Grgoire Ramade	Executive VP & Chief Commercial Officer
Mr. Philip Corrin	Senior Vice President of Operations & Supply Chain
Ms. Mary Wright	Chief Accounting Officer
Ms. Ryan Peterson	Associate Director of Investor Relations
Ms. Jennifer Yi Boyer	Executive VP of Enterprise Enablement & Chief Human Resources Officer
Dr. Krishna Jhaveri	Chief Medical Officer
Mr. Paul Andreassi	Senior Vice President of Quality & Regulatory Affairs

Important FAQs about investing in INGN Stock from India :

What is Inogen share price today?

Inogen share price today is $7.99 as on August 30, 2025 at 1:29 am IST at the close of the market. Inogen share today touched a day high of $7.99 and a low of $7.86.

What is the 52 week high and 52 week low for Inogen share?

Inogen share touched a 52 week high of $12.95 and a 52 week low of $5.70. Inogen stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.99, lower by 38.28% versus the 52 week high.

How to invest in Inogen Stock (INGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inogen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inogen Shares that will get you 0.1877 shares as per Inogen share price of $7.99 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inogen Stock (INGN) from India?

Indian investors can start investing in Inogen (INGN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inogen stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inogen share’s latest price of $7.99 as on August 30, 2025 at 1:29 am IST, you will get 1.2516 shares of Inogen. Learn more about fractional shares .

What are the returns that Inogen has given to Indian investors in the last 5 years?

Inogen stock has given -72.43% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?